SUMMIT 2024

We look forward to welcoming you to the 8th annual E-Cigarette Summit US, which will take place in Washington D.C on May 14 2024.

It was lovely to come back to Washington D.C last year and see so many people again in person.  We were pleased to have a full house and also to welcome so many on-line with the hybrid model.  The feedback was extremely positive, and we will continue to offer this as an option for all future Summits.

We have now made the videos from the 2023 Summit open access and they  can be viewed either on the Agenda Page or by clicking HERE

We will be updating this site with the 2024 speakers and agenda in due course.  The current agenda and speakers showing are from the 2023 event.

2023 KEYNOTE PRESENTERS

To view the full agenda and confirmed speakers please click HERE.

The Opening Keynote will be delivered by Dr Brian King Director for the Center for Tobacco Products at the Food and Drug Administration (FDA).  With almost two decades of experience in translating scientific evidence to inform tobacco control policies, Dr King joined the FDA in July 22 and is charged with ensuring that the CTP accomplishes its public health goals as it implements the Family Smoking Prevention and Tobacco Control ACT.

In the Closing Keynote, Tom Glynn will moderate a dialogue with Cliff Douglas and Mitch Zeller on the potential “End State” for tobacco control efforts.  Rather than focusing on the pros or cons of various harm reduction approaches, Cliff and Mitch will describe the differences between potentially competing visions for what “success” looks like.

In 1962 and 1964 respectively,  the UK’s Royal College of Physicians and the US Surgeon General,  published 2 ground breaking reports, which for the first time directly linked cigarette smoking with lung cancer.  These landmark publications were the catalyst for the modern-day tobacco control movement which for 60 years has seen the public health and tobacco control communities align around a single common goal – to end the smoking epidemic.

The emergence of e-cigarettes and novel nicotine products has introduced the first challenge to the consensus that formed around smoking, forcing us to consider whether the ultimate public health goal remains the defeat of the cigarette and its toll of death and disease, even if that means accepting the continued use of nicotine in society.  In resolving this dilemma, public health bodies are tasked with balancing concerns about youth initiation (and the perennial distrust of industry motivation), with the opportunity to potentially prevent millions of premature deaths.

In 2023, smoking remains the single biggest cause of preventable death and disease in the developed world and with over 30 million Americans still smoking, the need for a comprehensive tobacco control/public health plan has never been more important. The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest evidence and an opportunity to explore how this should be interpreted to deliver the most effective public health and regulatory strategies.